Abstract
Results of combination therapy of carboquone, cisplatin and OK-432 to primary non-small cell lung cancer
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have